IRONWOOD PHARMACEUTICALS INC - Class A common stock, $0.001 par value (CYTH)

Q: What does CUSIP 23254X201 represent in this 13F holders report?

CUSIP 23254X201 is the security identifier for CYTH - IRONWOOD PHARMACEUTICALS INC - Class A common stock, $0.001 par value used to aggregate holder disclosures.

Q: How many institutions held CYTH - IRONWOOD PHARMACEUTICALS INC - Class A common stock, $0.001 par value in Q2 2022?

10 institutional investors reported CYTH - IRONWOOD PHARMACEUTICALS INC - Class A common stock, $0.001 par value for Q2 2022. Use the holders table for investor-level position and value details.

CUSIP: 23254X201

Q2 2022 13F Holders as of 30 Jun 2022

Type / Class: Equity / Class A common stock, $0.001 par value
Shares outstanding: 162,474,849
Total 13F shares: 401,426
Share change: -31,719
Total reported value: $793,000
Price per share: $1.99
Number of holders: 10
Value change: -$77,588
Number of buys: 1
Number of sells: 5

Quarterly Holders Quick Answers

What is CUSIP 23254X201?
CUSIP 23254X201 identifies CYTH - IRONWOOD PHARMACEUTICALS INC - Class A common stock, $0.001 par value in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Related Filing Research

Latest 13F filings for newly reported positions.
Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
Latest 10-Q/10-K reports for financial context tied to this issuer.
Recent insider transactions for executive and insider activity.
SEC investors directory and top value investors for manager drilldown.
Back to full security ownership history.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2022
Previous quarter: Q1 2022

Recent filing periods for CUSIP 23254X201:

Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023

Institutional Holders of IRONWOOD PHARMACEUTICALS INC - Class A common stock, $0.001 par value (CYTH) as of Q2 2022

As of 30 Jun 2022, IRONWOOD PHARMACEUTICALS INC - Class A common stock, $0.001 par value (CYTH) was held by 10 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 401,426 shares. The largest 10 holders included VANGUARD GROUP INC, RENAISSANCE TECHNOLOGIES LLC, GEODE CAPITAL MANAGEMENT, LLC, STATE STREET CORP, Tower Research Capital LLC (TRC), WELLS FARGO & COMPANY/MN, CITIGROUP INC, UBS Group AG, MORGAN STANLEY, and BlackRock Inc.. This page lists 10 institutional shareholders reporting positions in this security for the Q2 2022 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.